Skip to Main Content

Paper Details

Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced Malignancies.
Clin Cancer Res
52
2020
Author NameAffiliation
Justin M WattsSylvester Comprehensive Cancer Center
Moshe TalpazUniversity of Michigan ann arbor
David C SmithUniversity of Michigan ann arbor
  • 1 - 3

Datasets

Release 1.2